1.48
price down icon6.33%   -0.10
after-market After Hours: 1.50 0.02 +1.35%
loading
Essa Pharma Inc stock is traded at $1.48, with a volume of 311.56K. It is down -6.33% in the last 24 hours and down -10.84% over the past month. ESSA Pharma Inc is a pharmaceutical company. The company was focused on the development of small-molecule drugs for the treatment of castration-resistant prostate cancer. It was developing drugs that selectively block the amino-terminal domain of the androgen receptor, potentially overcoming the known AR-dependent resistance mechanisms of CRPC and providing CRPC patients with the potential for increased progression-free and overall survival. Currently, the company has terminated its clinical trials and other studies.
See More
Previous Close:
$1.58
Open:
$1.57
24h Volume:
311.56K
Relative Volume:
1.47
Market Cap:
$65.70M
Revenue:
-
Net Income/Loss:
$-28.54M
P/E Ratio:
-2.3125
EPS:
-0.64
Net Cash Flow:
$-22.72M
1W Performance:
-5.13%
1M Performance:
-10.84%
6M Performance:
-75.50%
1Y Performance:
-81.86%
1-Day Range:
Value
$1.43
$1.59
1-Week Range:
Value
$1.43
$1.65
52-Week Range:
Value
$1.40
$8.59

Essa Pharma Inc Stock (EPIX) Company Profile

Name
Name
Essa Pharma Inc
Name
Phone
(778) 331-0962
Name
Address
SUITE 720, VANCOUVER, BC
Name
Employee
35
Name
Twitter
@essapharma
Name
Next Earnings Date
2025-02-11
Name
Latest SEC Filings
Name
EPIX's Discussions on Twitter

Compare EPIX with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
EPIX
Essa Pharma Inc
1.48 65.70M 0 -28.54M -22.72M -0.64
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
474.62 121.88B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
573.45 62.69B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
555.11 33.86B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
235.74 30.51B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
238.51 25.69B 3.81B -644.79M -669.77M -6.24

Essa Pharma Inc Stock (EPIX) Upgrades & Downgrades

Date Action Analyst Rating Change
Nov-04-24 Downgrade Jefferies Buy → Hold
Nov-04-24 Downgrade Oppenheimer Outperform → Perform
Nov-04-24 Downgrade Piper Sandler Overweight → Neutral
Jun-26-23 Resumed Oppenheimer Outperform
Mar-04-21 Initiated Piper Sandler Overweight
Jan-11-21 Reiterated H.C. Wainwright Buy
Nov-02-20 Initiated Jefferies Buy
Oct-25-19 Initiated Oppenheimer Outperform
View All

Essa Pharma Inc Stock (EPIX) Latest News

pulisher
Apr 01, 2025

We're Not Very Worried About ESSA Pharma's (NASDAQ:EPIX) Cash Burn Rate - Yahoo Finance

Apr 01, 2025
pulisher
Mar 25, 2025

The Gross Law Firm Reminds ESSA Pharma Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of March 25, 2025EPIX - PR Newswire

Mar 25, 2025
pulisher
Mar 25, 2025

ESSA Pharma Inc. Class Action: Levi & Korsinsky Reminds ESSA Pharma Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of March 25, 2025EPIX - PR Newswire

Mar 25, 2025
pulisher
Mar 25, 2025

INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of ESSA Pharma - Markets Insider

Mar 25, 2025
pulisher
Mar 25, 2025

EPIX Deadline Today: Rosen Law Firm Urges ESSA Pharma Inc. (NASDAQ: EPIX) Stockholders with Large Losses to Contact the Firm for Information About Their Rights - Business Wire

Mar 25, 2025
pulisher
Mar 24, 2025

ESSA Pharma Inc. Investors: Please contact the Portnoy Law - GlobeNewswire

Mar 24, 2025
pulisher
Mar 24, 2025

ONGOING DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of ESSA Pharma - Business Wire

Mar 24, 2025
pulisher
Mar 24, 2025

The Gross Law Firm Reminds ESSA Pharma Inc. Investors of the Pen - GuruFocus

Mar 24, 2025
pulisher
Mar 24, 2025

ESSA Pharma Inc. Securities Fraud Class Action Lawsuit - GlobeNewswire

Mar 24, 2025
pulisher
Mar 23, 2025

Shareholders that lost money on ESSA Pharma Inc.(EPIX) Urged to Join Class ActionContact Levi & Korsinsky to Learn More - ACCESS Newswire

Mar 23, 2025
pulisher
Mar 23, 2025

EPIX INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC - GlobeNewswire

Mar 23, 2025
pulisher
Mar 23, 2025

EPIX IMPORTANT DEADLINE: ROSEN, LEADING INVESTOR COUNSEL, - GlobeNewswire

Mar 23, 2025
pulisher
Mar 23, 2025

EPIX IMPORTANT DEADLINE: ROSEN, LEADING INVESTOR COUNSEL, Encourages ESSA Pharma Inc. Investors to Secure Counsel Before Important March 25 Deadline in Securities Class ActionEPIX - TradingView

Mar 23, 2025
pulisher
Mar 23, 2025

SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of ESSA Pharma - GlobeNewswire

Mar 23, 2025
pulisher
Mar 23, 2025

SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of ESSA Pharma - GlobeNewswire Inc.

Mar 23, 2025
pulisher
Mar 23, 2025

ESSA Pharma Inc. Faces Securities Fraud Class Action Over Alleged Investor Misleading Statements - Apna Kal

Mar 23, 2025
pulisher
Mar 22, 2025

Investors in ESSA Pharma Inc. Should Contact Levi & Korsinsky Before March 25, 2025 to Discuss Your RightsEPIX - ACCESS Newswire

Mar 22, 2025
pulisher
Mar 21, 2025

Faruqi & Faruqi Reminds ESSA Pharma Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of March 25, 2025EPIX - PR Newswire

Mar 21, 2025
pulisher
Mar 20, 2025

ESSA Pharma Inc. (NASDAQ: EPIX) Investor Alert: Deadline in Lawsuit on March 25, 2025 - openPR

Mar 20, 2025
pulisher
Mar 20, 2025

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against ESSA, Cardlytics, Novo Nordisk, and Crocs and Encourages Investors to Contact the Firm - TradingView

Mar 20, 2025
pulisher
Mar 20, 2025

EPIX DEADLINE: ROSEN, GLOBAL INVESTOR COUNSEL, Encourages ESSA Pharma Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important March 25 Deadline in Securities Class ActionEPIX - TradingView

Mar 20, 2025
pulisher
Mar 20, 2025

The Gross Law Firm Reminds ESSA Pharma Inc. Investors of - GlobeNewswire

Mar 20, 2025
pulisher
Mar 20, 2025

The Gross Law Firm Reminds ESSA Pharma Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of March 25, 2025 – EPIX - TradingView

Mar 20, 2025
pulisher
Mar 20, 2025

EPIX Lawsuit Alert! Class Action Lawsuit Against ESSA Pharma, Inc. - TipRanks

Mar 20, 2025
pulisher
Mar 19, 2025

EPIX Investors Have Final Opportunity Approaching to Lead ESSA Pharma Inc. Securities Fraud Lawsuit with the Schall Law Firm - Morningstar

Mar 19, 2025
pulisher
Mar 18, 2025

EPIX Deadline: EPIX Investors Have Opportunity to Lead ESSA Pharma Inc. Securities Fraud Lawsuit - PR Newswire

Mar 18, 2025
pulisher
Mar 18, 2025

Levi & Korsinsky Notifies Shareholders of ESSA Pharma - GlobeNewswire

Mar 18, 2025
pulisher
Mar 17, 2025

EPIX DEADLINE: ROSEN, RECOGNIZED INVESTOR COUNSEL, - GlobeNewswire

Mar 17, 2025
pulisher
Mar 17, 2025

INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of ESSA Pharma - StreetInsider.com

Mar 17, 2025
pulisher
Mar 17, 2025

2025-03-17 | INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of ESSA Pharma | NDAQ:EPIX | Press Release - Stockhouse Publishing

Mar 17, 2025
pulisher
Mar 17, 2025

INVESTOR ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against ESSA Pharma Inc. and Certain OfficersEPIX - PR Newswire

Mar 17, 2025
pulisher
Mar 17, 2025

ESSA Pharma Inc. Class Action: The Gross Law Firm Reminds ESSA Pharma Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of March 25, 2025EPIX - PR Newswire

Mar 17, 2025
pulisher
Mar 16, 2025

2025-03-16 | ESSA Pharma Inc. Sued for Securities Law ViolationsInvestors Should Contact Levi & Korsinsky Before March 25, 2025 to Discuss Your RightsEPIX | NDAQ:EPIX | Press Release - Stockhouse Publishing

Mar 16, 2025
pulisher
Mar 16, 2025

EPIX Stockholders Have Opportunity to Lead ESSA Pharma Inc. Class Action Lawsuit – Contact Bronstein, Gewirtz and Grossman, LLC Today! - Markets Insider

Mar 16, 2025
pulisher
Mar 15, 2025

INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP - GlobeNewswire

Mar 15, 2025
pulisher
Mar 14, 2025

Levi & Korsinsky Notifies ESSA Pharma Inc. Investors of a Class Action Lawsuit and Upcoming DeadlineEPIX - Stockhouse Publishing

Mar 14, 2025
pulisher
Mar 14, 2025

EPIX FINAL DEADLINE: ROSEN, A LEADING LAW FIRM, Encourages - GlobeNewswire

Mar 14, 2025
pulisher
Mar 14, 2025

EPIX FINAL DEADLINE: ROSEN, A LEADING LAW FIRM, Encourages ESSA Pharma Inc. Investors to Secure Counsel Before Important March 25 Deadline in Securities Class Action - GlobeNewswire Inc.

Mar 14, 2025
pulisher
Mar 14, 2025

EPIX INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that ESSA Pharma Inc. Stockholders with Losses Have Opportunity to Lead Class Action Lawsuit! - Markets Insider

Mar 14, 2025
pulisher
Mar 14, 2025

2025-03-14 | Investors who lost money on ESSA Pharma Inc.(EPIX) should contact Levi & Korsinsky about pending Class ActionEPIX | NDAQ:EPIX | Press Release - Stockhouse Publishing

Mar 14, 2025
pulisher
Mar 14, 2025

EPIX Investors Have Opportunity to Lead ESSA Pharma Inc. Securities Fraud Lawsuit with the Schall Law Firm - Morningstar

Mar 14, 2025
pulisher
Mar 13, 2025

ESSA Pharma Inc. Investors: Please contact the Portnoy Law Firm to recover your losses. March ... - The Bakersfield Californian

Mar 13, 2025
pulisher
Mar 13, 2025

ESSA Pharma Inc. Investors: Please contact the Portnoy Law Firm to recover your losses. March 25, 2025 Deadline to file Lead Plaintiff Motion - TradingView

Mar 13, 2025
pulisher
Mar 13, 2025

EPIX LAWSUIT ALERT: Levi & Korsinsky Notifies ESSA Pharma - GlobeNewswire

Mar 13, 2025
pulisher
Mar 13, 2025

EPIX INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that ESSA Pharma Inc. Shareholders with Losses Have Opportunity to Lead Class Action Lawsuit! - Markets Insider

Mar 13, 2025
pulisher
Mar 13, 2025

SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of ESSA Pharma - PR Newswire

Mar 13, 2025
pulisher
Mar 13, 2025

March 25, 2025 Deadline: Contact The Gross Law Firm to Join Class Action Suit Against EPIX - PR Newswire

Mar 13, 2025
pulisher
Mar 12, 2025

EPIX SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that ESSA Pharma Inc. Shareholders Have Opportunity to Lead Class Action Lawsuit! - Markets Insider

Mar 12, 2025
pulisher
Mar 12, 2025

Class Action Filed Against ESSA Pharma Inc. (EPIX) Seeking Recovery for InvestorsContact Levi & Korsinsky - Stockhouse Publishing

Mar 12, 2025
pulisher
Mar 12, 2025

ROSEN, A LEADING LAW FIRM, Encourages ESSA Pharma Inc. - GlobeNewswire

Mar 12, 2025
pulisher
Mar 11, 2025

Levi & Korsinsky Notifies Shareholders of ESSA Pharma Inc. (EPIX) of a Class Action Lawsuit and an Upcoming Deadline - ACCESS Newswire

Mar 11, 2025

Essa Pharma Inc Stock (EPIX) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$60.58
price down icon 3.01%
$69.18
price down icon 5.66%
$17.36
price down icon 8.20%
$31.11
price down icon 2.14%
$88.05
price down icon 4.30%
biotechnology ONC
$238.51
price down icon 9.76%
Cap:     |  Volume (24h):